Shares of Genpact Limited (NYSE:G) rose 8% today following a strong fourth-quarter earnings report that exceeded consensus ...
This new series profiles the members of edie's 30 Under 30 - a nomination-based community of 30 hugely talented young ...
The widely followed cryptocurrency analyst Benjamin Cowen is warning that Ethereum (ETH) could slide further against Bitcoin ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Kura Oncology (KURA – Research Report) today. The company’s shares closed yesterday at ...
TD Cowen reinstated coverage on Tempus AI with a "Buy" rating and raised its price target to $74 after the health-tech ...
Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...
President Donald Trump has continued his shake-up of NLRB leadership by firing Acting General Counsel (GC) Jessica Rutter and replacing her ...
Noting that Ambry is a profitable testing laboratory that generates more than $300 million of revenue annually, the investment bank thinks that the deal will enable TEM to start generating positive ...
In a report released today, Marc Bianchi from TD Cowen maintained a Buy rating on NOV (NOV – Research Report), with a price target of $22.00.
After a winter storm dumped more rain into the Basin after a relatively dry winter, Barton Hospital’s new site on Highway 50 ...
The analysts say a bundle is a better model for traditional TV giants like WBD, Disney, and Paramount. Netflix is another ...